AXL receptor tyrosine kinase is increased in patients with heart failure

International Journal of Cardiology

Volumn 173, Issue 3, 2014, Pages 402-409

  Batlle, M ^a,b   Recarte Pelz, P ^a,c   Roig, E ^d   Castel, M A ^a,b   Cardona, M ^a,b   Farrero, M ^a,b   Ortiz, J T ^a,b   Campos, B ^e   Pulgarin M J ^a,b   Ramirez J ^b   Perez Villa F ^a,b   Garcia De Frutos P ^a,c  

^a INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

^c INST D INVESTIGACIONS B   (Spain)

^d HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^e UNIVERSITY OF BARCELONA   (Spain)

Author keywords

AXL receptor tyrosine kinase; Heart failure; Myocardial damage; Prognosis

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; CALCIUM ANTAGONIST; CREATININE; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDRALAZINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITRATE; PROTEIN AXL; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG; AXL RECEPTOR TYROSINE KINASE; BIOLOGICAL MARKER; ONCOPROTEIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART MUSCLE BIOPSY; HEART MUSCLE INJURY; HEART TRANSPLANTATION; HOSPITALIZATION; HUMAN; HUMAN TISSUE; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SYSTOLIC BLOOD PRESSURE; WESTERN BLOTTING; AGED; BLOOD; CLINICAL TRIAL; DISEASE FREE SURVIVAL; ENZYMOLOGY; HEART MUSCLE; MIDDLE AGED; MULTICENTER STUDY;

AGED; BIOLOGICAL MARKERS; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; MYOCARDIUM; PROTO-ONCOGENE PROTEINS; RECEPTOR PROTEIN-TYROSINE KINASES;

EID: 84899427154     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2014.03.016     Document Type: Article

References (53)

1. P.A. Heidenreich, J.G. Trogdon, and O.A. Khavjou et al. Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association Circulation 123 8 Mar 1 2011 933 944
2. J.J. McMurray, S. Adamopoulos, and S.D. Anker et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC Eur J Heart Fail 14 8 Aug 2012 803 869
3. The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: an individual patient data meta-analysis Eur Heart J 33 14 Jul 2012 1750 1757
4. J.O. Mudd, and D.A. Kass Tackling heart failure in the twenty-first century Nature 451 7181 Feb 21 2008 919 928
5. R.S. Whelan, V. Kaplinskiy, and R.N. Kitsis Cell death in the pathogenesis of heart disease: mechanisms and significance Annu Rev Physiol 72 2010 19 44
6. L. Bellido-Martin, and P.G. de Frutos Vitamin K-dependent actions of Gas6 Vitam Horm 78 2008 185 209
7. P. Evenas, F.P. Garcia de, G.A. Nicolaes, and B. Dahlback The second laminin G-type domain of protein S is indispensable for expression of full cofactor activity in activated protein C-catalysed inactivation of factor Va and factor VIIIa Thromb Haemost 84 2 Aug 2000 271 277
8. S. Clauser, O. Meilhac, and I. Bieche et al. Increased secretion of Gas6 by smooth muscle cells in human atherosclerotic carotid plaques Thromb Haemost 107 1 Jan 2012 140 149
9. B. Hurtado, X. Munoz, and P. Recarte-Pelz et al. Expression of the vitamin K-dependent proteins GAS6 and protein S and the TAM receptor tyrosine kinases in human atherosclerotic carotid plaques Thromb Haemost 105 5 May 2011 873 882
10. A.I. Su, T. Wiltshire, and S. Batalov et al. A gene atlas of the mouse and human protein-encoding transcriptomes Proc Natl Acad Sci U S A 101 16 Apr 20 2004 6062 6067
11. C. Ekman, J. Stenhoff, and B. Dahlback Gas6 is complexed to the soluble tyrosine kinase receptor Axl in human blood J Thromb Haemost 8 4 Apr 2010 838 844
12. S. Scutera, T. Fraone, and T. Musso et al. Survival and migration of human dendritic cells are regulated by an IFN-alpha-inducible Axl/Gas6 pathway J Immunol 183 5 Sep 1 2009 3004 3013
13. M. Batlle, E. Roig, and F. Perez-Villa et al. Increased expression of the renin-angiotensin system and mast cell density but not of angiotensin- converting enzyme II in late stages of human heart failure J Heart Lung Transplant 25 9 Sep 2006 1117 1125
14. G. Casals, L. Azzalini, and C. Tomas et al. Admission B-type natriuretic peptide retains prognostic value in patients with acute coronary syndrome and preserved left ventricular ejection fraction Int J Cardiol 158 3 Jul 26 2012 459 460
15. L. Fernandez-Fernandez, L. Bellido-Martin, and dF Garcia Growth arrest-specific gene 6 (GAS6). An outline of its role in haemostasis and inflammation Thromb Haemost 100 4 Oct 2008 604 610
16. S. Laurance, C.A. Lemarie, and M.D. Blostein Growth arrest-specific gene 6 (gas6) and vascular hemostasis Adv Nutr 3 2 Mar 2012 196 203
17. M. Tjwa, L. Bellido-Martin, and Y. Lin et al. Gas6 promotes inflammation by enhancing interactions between endothelial cells, platelets, and leukocytes Blood 111 8 Apr 15 2008 4096 4105
18. V.A. Korshunov, A.M. Mohan, M.A. Georger, and B.C. Berk Axl, a receptor tyrosine kinase, mediates flow-induced vascular remodeling Circ Res 98 11 Jun 9 2006 1446 1452
19. J. Gerloff, and V.A. Korshunov Immune modulation of vascular resident cells by Axl orchestrates carotid intima-media thickening Am J Pathol 180 5 May 2012 2134 2143
20. A. Konishi, T. Aizawa, A. Mohan, V.A. Korshunov, and B.C. Berk Hydrogen peroxide activates the Gas6-Axl pathway in vascular smooth muscle cells J Biol Chem 279 27 Jul 2 2004 28766 28770
21. V.A. Korshunov, M. Daul, M.P. Massett, and B.C. Berk Axl mediates vascular remodeling induced by deoxycorticosterone acetate-salt hypertension Hypertension 50 6 Dec 2007 1057 1062
22. G. Collett, A. Wood, and M.Y. Alexander et al. Receptor tyrosine kinase Axl modulates the osteogenic differentiation of pericytes Circ Res 92 10 May 30 2003 1123 1129
23. G.D. Collett, A.P. Sage, J.P. Kirton, M.Y. Alexander, A.P. Gilmore, and A.E. Canfield Axl/phosphatidylinositol 3-kinase signaling inhibits mineral deposition by vascular smooth muscle cells Circ Res 100 4 Mar 2 2007 502 509
24. B.K. Son, K. Kozaki, and K. Iijima et al. Statins protect human aortic smooth muscle cells from inorganic phosphate-induced calcification by restoring Gas6-Axl survival pathway Circ Res 98 8 Apr 28 2006 1024 1031
25. E. Braunwald Biomarkers in heart failure N Engl J Med 358 20 May 15 2008 2148 2159
26. S. Wiese, T. Breyer, and A. Dragu et al. Gene expression of brain natriuretic peptide in isolated atrial and ventricular human myocardium: influence of angiotensin II and diastolic fiber length Circulation 102 25 Dec 19 2000 3074 3079
27. H. Yasue, M. Yoshimura, and H. Sumida et al. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure Circulation 90 1 Jul 1994 195 203
28. A.S. Maisel, P. Krishnaswamy, and R.M. Nowak et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure N Engl J Med 347 3 Jul 18 2002 161 167
29. C.W. Yancy, M. Jessup, and B. Bozkurt et al. ACCF/AHA Guideline for the Management of Heart Failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 62 16 Jun 5 2013 e147 e239
30. S.J. Pocock, C.A. Ariti, and J.J. McMurray et al. Predicting survival in heart failure: a risk score based on 39 372 patients from 30 studies Eur Heart J 34 19 May 2013 1404 1413
31. I.J. Lee, B. Hilliard, and A. Swami et al. Growth arrest-specific gene 6 (Gas6) levels are elevated in patients with chronic renal failure Nephrol Dial Transplant 27 11 Nov 2012 4166 4172
32. M. Yanagita Gas6, warfarin, and kidney diseases Clin Exp Nephrol 8 4 Dec 2004 304 309
33. A.P. Ambrosy, M. Vaduganathan, and M.D. Huffman et al. Clinical course and predictive value of liver function tests in patients hospitalized for worsening heart failure with reduced ejection fraction: an analysis of the EVEREST trial Eur J Heart Fail 14 3 Mar 2012 302 311
34. Y.D. Tang, and S.D. Katz Anemia in chronic heart failure: prevalence, etiology, clinical correlates, and treatment options Circulation 113 20 May 23 2006 2454 2461
35. S.D. Anker, W. Doehner, and M. Rauchhaus et al. Uric acid and survival in chronic heart failure: validation and application in metabolic, functional, and hemodynamic staging Circulation 107 15 Apr 22 2003 1991 1997
36. M. Davis, E. Espiner, and G. Richards et al. Plasma brain natriuretic peptide in assessment of acute dyspnoea Lancet 343 8895 Feb 19 1994 440 444
37. J.L. Januzzi, R. van Kimmenade, and J. Lainchbury et al. NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: the International Collaborative of NT-proBNP Study Eur Heart J 27 3 Feb 2006 330 337
38. W.H. Tang, G.S. Francis, and D.A. Morrow et al. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: clinical utilization of cardiac biomarker testing in heart failure Clin Biochem 41 4-5 Mar 2008 210 221
39. R. Berger, M. Huelsman, and K. Strecker et al. B-type natriuretic peptide predicts sudden death in patients with chronic heart failure Circulation 105 20 May 21 2002 2392 2397
40. F.L. Dini, A. Gabutti, C. Passino, P. Fontanive, M. Emdin, and S.M. De Tommasi Atrial fibrillation and amino-terminal pro-brain natriuretic peptide as independent predictors of prognosis in systolic heart failure Int J Cardiol 140 3 Apr 30 2010 344 350
41. G.C. Fonarow, W.F. Peacock, C.O. Phillips, M.M. Givertz, and M. Lopatin Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure J Am Coll Cardiol 49 19 May 15 2007 1943 1950
42. J. Koglin, S. Pehlivanli, M. Schwaiblmair, M. Vogeser, P. Cremer, and W. vonScheidt Role of brain natriuretic peptide in risk stratification of patients with congestive heart failure J Am Coll Cardiol 38 7 Dec 2001 1934 1941
43. A. Maisel, C. Mueller, and K. Adams et al. State of the art: using natriuretic peptide levels in clinical practice Eur J Heart Fail 10 9 Sep 2008 824 839
44. D.J. van Veldhuisen, G.C. Linssen, and T. Jaarsma et al. B-type natriuretic peptide and prognosis in heart failure patients with preserved and reduced ejection fraction J Am Coll Cardiol 61 14 Apr 9 2013 1498 1506
45. C.G. Jungbauer, J. Riedlinger, and S. Buchner et al. High-sensitive troponin T in chronic heart failure correlates with severity of symptoms, left ventricular dysfunction and prognosis independently from N-terminal pro-b-type natriuretic peptide Clin Chem Lab Med 49 11 Nov 2011 1899 1906
46. M.N. Zairis, G.Z. Tsiaousis, and A.T. Georgilas et al. Multimarker strategy for the prediction of 31 days cardiac death in patients with acutely decompensated chronic heart failure Int J Cardiol 141 3 Jun 11 2010 284 290
47. D.A. Pascual-Figal, S. Manzano-Fernandez, and M. Boronat et al. Soluble ST2, high-sensitivity troponin T- and N-terminal pro-B-type natriuretic peptide: complementary role for risk stratification in acutely decompensated heart failure Eur J Heart Fail 13 7 Jul 2011 718 725
48. E.O. Weinberg, M. Shimpo, S. Hurwitz, S. Tominaga, J.L. Rouleau, and R.T. Lee Identification of serum soluble ST2 receptor as a novel heart failure biomarker Circulation 107 5 Feb 11 2003 721 726
49. A. Bayes-Genis, A.M. de, and A. Galan et al. Combined use of high-sensitivity ST2 and NTproBNP to improve the prediction of death in heart failure Eur J Heart Fail 14 1 Jan 2012 32 38
50. D.J. Lok, M.P. van der, and P.W. de la Porte et al. Prognostic value of galectin-3, a novel marker of fibrosis, in patients with chronic heart failure: data from the DEAL-HF study Clin Res Cardiol 99 5 May 2010 323 328
51. R.R. van Kimmenade, J.L. Januzzi Jr., and P.T. Ellinor et al. Utility of amino-terminal pro-brain natriuretic peptide, galectin-3, and apelin for the evaluation of patients with acute heart failure J Am Coll Cardiol 48 6 Sep 19 2006 1217 1224
52. S. Monteiro, F. Franco, and S. Costa et al. Prognostic value of CA125 in advanced heart failure patients Int J Cardiol 140 1 Apr 1 2010 115 118
53. J. Nunez, J. Sanchis, and V. Bodi et al. Improvement in risk stratification with the combination of the tumour marker antigen carbohydrate 125 and brain natriuretic peptide in patients with acute heart failure Eur Heart J 31 14 Jul 2010 1752 1763